RAC1 and hepatocellular carcinoma: Importantly, GLS2 show anti-oncogenic roles independently of its glutaminolysis function in HCC, allowing metastasis suppression through Rac1 activation43 and repression of the epithelial-mesenchymal transition through the Dicer-miR-34a-Snail axis23.